References
- Adler V, Yin Z, Fuchs SY, et al. (1999). Regulation of JNK signalling by GSTpi. EMBO J 18:1321–1334.
- Altshuler LL, Cohen L, Szuba MP, et al. (1996). Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153:592–606.
- Alwan S, Reefhuis J, Rasmussen SA, et al. (2007). Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692.
- Aranoff GR, Berstrom RF, Potrattz ST, et al. (1984). Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther 36:138–144.
- Baranczyk-Kuzma A, Kuzma H, Gutowicz M, et al. (2004). Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim Pol 51:207–212.
- Bebbington PE, Dunn G, Jenkins R, et al. (1998). The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Psychol Med 28:9–19.
- Bergstrom RF, Lemberger L, Farid NA, Wolen RL. (1988). Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Phychiatry 153:47–50.
- Berk M. (2007). Oxidative biology: new intervention opportunities in psychiatry. Acta Neuropsychiatr 19:259–260.
- Bernardini S, Bernassola F, Cortese C, et al. (2000). Modulation of GST P1-1 activity by polymerization during apoptosis. J Cell Biochem 77:645–653.
- Bilici M, Efe H, Koroglu MA, et al. (2001). Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43–51.
- Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
- Brunswick DJ, Amsterdam JD, Fawcett J, et al. (2002). Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. J Affect Disord 68:243–249.
- Crewe HK, Lennard MS, Tucker GT, et al. (1992). The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 34:262–265.
- Dalmizrak O, Kulaksiz-Erkmen G, Ozer N. (2011). The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine. Mol Cell Biochem 355:223–231.
- Dalmizrak O, Kulaksiz-Erkmen G, Ozer N. (2012). Possible prenatal impact of sertraline on human placental glutathione S-transferase-π. Hum Exp Toxicol 31:457–464.
- De Kloet ER, Joels M, Holsboer F. (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475.
- Ewing G, Tatarchuk Y, Appleby D, et al. (2015). Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome. Clin Pharmacokinet 54:359–370.
- Gram LF. (1994). Drug therapy: fluoxetine. N Eng J Med 17:1354–1361.
- Habig WH, Jakoby WB. (1981). Assays for differentiation of glutathione S-transferases. Methods Enzymol 77:398–405.
- Hallberg P, Sjöblom V. (2005). The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 25:59–73.
- Hayes JD, Flanagan JU, Jowsey IR. (2005). Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88.
- Hendrick V, Stowe ZN, Altshuler LL, et al. (2003). Placental passage of antidepressant medications. Am J Psychiatry 160:993–996.
- Henry ME, Schmidt ME, Hennen J, et al. (2005). A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 30:1576–1583.
- Hiemke C, Hartter S. (2000). Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85:11–28.
- Inkielewicz-Stepniak I. (2011). Impact of fluoxetine on liver damage in rats. Pharmacol Rep 63:441–447.
- Kallen B, Otterblad Olausson P. (2006). Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21:221–222.
- Ketterer B. (2001). A bird’s eye view of the glutathione transferase field. Chem Biol Interact 138:27–42.
- Koenig AM, Thase ME. (2009). First-line pharmacotherapies for depression – what is the best choice? Pol Arch Med Wewn 119:478–486..
- Mannervik B, Board PG, Hayes JD, et al. (2005). Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 401:1–8.
- Morrison JL, Riggs KW, Rurak DW. (2005). Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 17:641–650.
- Myren M, Mose T, Mathiesen L, Knudsen LE. (2007). The human placenta-An alternative for studying foetal exposure. Toxicol In Vitro 21:1332–1340.
- Nakhai-Pour HR, Broy P, Berard A. (2010). Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 13:1031–1037.
- Pato MT, Murphy DL, DeVane CL. (1991). Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J Clin Psychopharmacol 11:224–225.
- Pedersen LH, Henriksen TB, Vestergaard M, et al. (2009). Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339:6.
- Pérez V, Puiigdemont D, Gilaberte I, et al. (2001). Augmentation of fluoxetine’s antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. J Clin Psychopharmacol 21:36–45.
- Ralat LA, Colman RF. (2004). Glutathione S-transferase pi has at least three distinguishable xenobiotic substrate sites close to its glutathione-binding site. J Biol Chem 279:50204–50213.
- Reis M, Kallen B. (2010). Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40:1723–1733.
- Sandson NB, Armstrong SC, Cozza KL. (2005). An overview of psychotropic drug-drug interactions. Psychosomatics 46:464–494.
- Schildkraut JJ. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522.
- Segel IH. (1975). Enzyme kinetics. New York: A Wiley-Interscience Publication
- Shearer WT, Shreiner RL, Marshall RE. (1972). Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 81:570–572.
- Strange RC, Spiteri MA, Ramachandran S, Fryer AA. (2001). Glutathione-S-transferase family of enzymes. Mutat Res 482:21–26.
- Townsend DM, Manevich Y, Hutchens S, et al. (2009). Novel role for glutathione S-transferase π: regulator of protein – glutathionylation following oxidative and nitrosative stres. J Biol Chem 284:436–445.
- Wong DT, Perry KW, Bymaster FP. (2005). Case history: the discovery of fluoxetine hydrochloride. Nature 4:764–774.
- Zafir A, Ara A, Banu N. (2009). Invivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 33:220–228.